Work

Interim Analysis of a Phase I Study of Veliparib With Gemcitabine and IMRT in Patients With Borderline and Locally Advanced Unresectable Pancreatic Cancer

FWCI: 0.146
Cites:
Cited by: 1
Related to: 10